
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Do you depend on T-shirts to protect you from the sun's damaging rays? They may not block as much ultraviolet light as you think.